Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Elabd

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical and Experimental Medicine|April 10, 2025
Circulating miR-485-5p as a potential diagnostic and prognostic biomarker for HCV-related hepatocellular carcinomaGamalat A Elgedawy, Naglaa S Elabd, Asmaa M Elbrolosy, et al.
Biochemistry and Biophysics Reports|July 18, 2025
Promotive role of MBNL3 and PXN genes expressions with lncRNA PXN-AS1-L on gastric cancerMai A H Abouelenin, Amany A Saleh, Naglaa S Elabd, et al.
Journal of Infection in Developing Countries|July 3, 2025
Insights into correlations between H. pylori infection and chronic hepatitis C disease progression: A Comparative study in the Egyptian populationAhmed Ragab, Asmaa M Elbrolosy, Naglaa S Elabd, et al.
Virus Research|January 4, 2011
WITHDRAWN: Caprine antibodies towards E2 conserved peptides interfere with hepatitis C virus infectivity in vitroYasmine S Elabd, Ashraf A Tabll, Noha G Bader El Din, et al.
Hepatic Medicine : Evidence and Research|March 24, 2021
Evaluation of MicroRNA-122 as a Biomarker for Chronic Hepatitis C Infection and as a Predictor for Treatment Response to Direct-Acting AntiviralsNaglaa S Elabd, Safaa I Tayel, Moamena S Elhamouly, et al.
The Application of Clinical Genetics|August 8, 2022
Long Non-Coding RNAs ASB16-AS1 and AFAP1-AS1: Diagnostic, Prognostic Impact and Survival Analysis in Colorectal CancerNaglaa S Elabd, Shimaa E Soliman, Moamena S Elhamouly, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|July 29, 2024
Insights into the Correlation between Toll-Like Receptor 2 Polymorphism and HBV-Related Disease Progression and Occurrence of Hepatocellular Carcinoma: A Case-Control Study in Egyptian PatientsNaglaa S Elabd, Marwa L Helal, Mohsen Elkhayat, et al.
Plos One|May 30, 2024
Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learningGamalat A Elgedawy, Mohamed Samir, Naglaa S Elabd, et al.
Infection|May 4, 2024
FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case-control study in Egyptian patientsGamalat A Elgedawy, Naglaa S Elabd, Radwa H Salem, et al.
Molecular Biology Reports|December 2, 2025
The influence of blood levels of circRNAs and microRNAs on the development of ulcerative colitisMai A H Abouelenin, Safaa I Tayel, Amany A Saleh, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical and Experimental Medicine|April 10, 2025
Circulating miR-485-5p as a potential diagnostic and prognostic biomarker for HCV-related hepatocellular carcinomaGamalat A Elgedawy, Naglaa S Elabd, Asmaa M Elbrolosy, et al.
Biochemistry and Biophysics Reports|July 18, 2025
Promotive role of MBNL3 and PXN genes expressions with lncRNA PXN-AS1-L on gastric cancerMai A H Abouelenin, Amany A Saleh, Naglaa S Elabd, et al.
Journal of Infection in Developing Countries|July 3, 2025
Insights into correlations between H. pylori infection and chronic hepatitis C disease progression: A Comparative study in the Egyptian populationAhmed Ragab, Asmaa M Elbrolosy, Naglaa S Elabd, et al.
Virus Research|January 4, 2011
WITHDRAWN: Caprine antibodies towards E2 conserved peptides interfere with hepatitis C virus infectivity in vitroYasmine S Elabd, Ashraf A Tabll, Noha G Bader El Din, et al.
Hepatic Medicine : Evidence and Research|March 24, 2021
Evaluation of MicroRNA-122 as a Biomarker for Chronic Hepatitis C Infection and as a Predictor for Treatment Response to Direct-Acting AntiviralsNaglaa S Elabd, Safaa I Tayel, Moamena S Elhamouly, et al.
The Application of Clinical Genetics|August 8, 2022
Long Non-Coding RNAs ASB16-AS1 and AFAP1-AS1: Diagnostic, Prognostic Impact and Survival Analysis in Colorectal CancerNaglaa S Elabd, Shimaa E Soliman, Moamena S Elhamouly, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|July 29, 2024
Insights into the Correlation between Toll-Like Receptor 2 Polymorphism and HBV-Related Disease Progression and Occurrence of Hepatocellular Carcinoma: A Case-Control Study in Egyptian PatientsNaglaa S Elabd, Marwa L Helal, Mohsen Elkhayat, et al.
Plos One|May 30, 2024
Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learningGamalat A Elgedawy, Mohamed Samir, Naglaa S Elabd, et al.
Infection|May 4, 2024
FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case-control study in Egyptian patientsGamalat A Elgedawy, Naglaa S Elabd, Radwa H Salem, et al.
Molecular Biology Reports|December 2, 2025
The influence of blood levels of circRNAs and microRNAs on the development of ulcerative colitisMai A H Abouelenin, Safaa I Tayel, Amany A Saleh, et al.
Pageof 2